Amylou Dueck, PhD

Associate Professor

  • 6154 Citations
  • 42 h-Index
20042020
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 4 Similar Profiles
Neoplasms Medicine & Life Sciences
Breast Neoplasms Medicine & Life Sciences
Clinical Trials Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Primary Myelofibrosis Medicine & Life Sciences
Quality of Life Medicine & Life Sciences
Terminology Medicine & Life Sciences
National Cancer Institute (U.S.) Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2015 2020

Multiple Myeloma
Oncolytic Virotherapy
Clonal Evolution
Vesicular Stomatitis
Research

Research Output 2004 2019

1 Citation (Scopus)

Can Methods Developed for Interpreting Group-level Patient-reported Outcome Data be Applied to Individual Patient Management?

King, M. T., Dueck, A. & Revicki, D. A., May 1 2019, In : Medical Care. 57, p. S38-S45

Research output: Contribution to journalArticle

Decision Making
Patient Reported Outcome Measures
Qualitative Research
Calibration
Reference Values

Patient free text reporting of symptomatic adverse events in cancer clinical research using the National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

Chung, A. E., Shoenbill, K., Mitchell, S. A., Dueck, A., Schrag, D., Bruner, D. W., Minasian, L. M., St Germain, D., O'Mara, A. M., Baumgartner, P., Rogak, L. J., Abernethy, A. P., Griffin, A. C. & Basch, E. M., Feb 20 2019, In : Journal of the American Medical Informatics Association. 26, 4, p. 276-285 10 p.

Research output: Contribution to journalArticle

National Cancer Institute (U.S.)
Terminology
Medical Dictionaries
Research
Neoplasms

Perceived risk for cancer progression and psychological status in chronic lymphocytic leukemia patients: CALGB 70603 (Alliance)

Deshields, T. L., Dueck, A., Rogers, K., Brown, J. R., Shanafelt, T., Mintzer, D. & Byrd, J. C., Jan 1 2019, In : Leukemia and Lymphoma.

Research output: Contribution to journalLetter

B-Cell Chronic Lymphocytic Leukemia
Psychology
Neoplasms

Phase II trial of Lestaurtinib, a JAK2 inhibitor, in patients with myelofibrosis

Mascarenhas, J., Baer, M. R., Kessler, C., Hexner, E., Tremblay, D., Price, L., Sandy, L., Weinberg, R., Pahl, H., Silverman, L. R., Goldberg, J. D., Kosiorek, H., Dueck, A. & Hoffman, R., Jan 1 2019, (Accepted/In press) In : Leukemia and Lymphoma.

Research output: Contribution to journalArticle

Primary Myelofibrosis
lestaurtinib
2 Citations (Scopus)

Two-Year Survival Comparing Web-Based Symptom Monitoring vs Routine Surveillance Following Treatment for Lung Cancer

Denis, F., Basch, E., Septans, A. L., Bennouna, J., Urban, T., Dueck, A. & Letellier, C., Jan 22 2019, In : JAMA - Journal of the American Medical Association. 321, 3, p. 306-307 2 p.

Research output: Contribution to journalLetter

Lung Neoplasms